Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 2
2(66.7%)
N/A
1(33.3%)
3Total
Phase 2(2)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07171411Not ApplicableCompleted

Combined Whey Protein and Collagen Supplementation in Resistance-Trained Men

Role: collaborator

NCT02681458Completed

Superficial and Cutaneous Fungal Infections Among Drug-users in Northeast Region of Iran

Role: lead

NCT01268449Phase 2Completed

Evaluation of Low Dose Laser in Treatment of Tinnitus

Role: lead

NCT00555776Phase 2Unknown

Effect of Gabapentin on Idiopathic Subjective Tinnitus

Role: lead

All 4 trials loaded